Inventor
Michael Feldhaus
Inventor
Grantham, NH, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12NMicroorganisms or enzymes10%
C40BCombinatorial chemistry10%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology3%
G16CComputational chemistry3%
C12YEnzymes2%
PatentTitleYear
11,091,559Anti-ALK antibodies and methods for use thereof202111,078,291BCMA antibodies and use of same to treat cancer and immunological disorders202111,008,383Rationally designed, synthetic antibody libraries and uses therefor202111,008,403Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use202111,008,568Rationally designed, synthetic antibody libraries and uses therefor202110,889,811Antibody libraries202110,882,920Antibodies against BACE1 and use thereof for neural disease immunotherapy202110,196,635Rationally designed, synthetic antibody libraries and uses therefor201910,189,894Rationally designed, synthetic antibody libraries and uses therefor201910,138,478Antibody libraries201810,072,299Antibodies against epidermal growth factor receptor (EGFR) and uses thereof20189,902,999'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20189,885,087'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20189,487,588'Antibodies against the ectodomain of ERBB3 and uses thereof'20169,354,228'Antibody libraries'20169,226,964'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20169,044,460'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20158,961,966'Antibodies against ERBB3 and uses thereof'20158,927,694'Human serum albumin linkers and conjugates thereof'20158,877,688'Rationally designed, synthetic antibody libraries and uses therefor'20148,691,730'Rationally designed, synthetic antibody libraries and uses therefor'20148,691,225'Antibodies against the ectodomain of ErbB3 and uses thereof'20147,846,440'Antibodies against ErbB3 and uses thereof'20106,060,240'Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000Based in Salt Lake City, UT, US· patent location history
2010–2018Patents assigned to MERRIMACK PHARMACEUTICALS INC (10)· patent assignee history
2010–2021Based in Grantham, NH, US· patent location history
2014–2021Patents assigned to ADIMAB LLC (11)· patent assignee history
2014–2016Patents assigned to FELDHAUS MICHAEL (7)· patent assignee history
2014–2015Patents assigned to NIELSEN ULRIK (3)· patent assignee history
2014–2016Patents assigned to VASQUEZ MAXIMILIANO (3)· patent assignee history
2014Based in Belmont, MA, US· patent location history
2021Based in Lebanon, NH, US· patent location history
2021Based in Lebanon, OH, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ADIMAB LLC | 11 | 2014–2021 |
| MERRIMACK PHARMACEUTICALS INC | 10 | 2010–2018 |
| FELDHAUS MICHAELself | 7 | 2014–2016 |
| NIELSEN ULRIK | 3 | 2014–2015 |
| VASQUEZ MAXIMILIANO | 3 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Grantham, NH, US | 16 | 2010–2021 |
| Lebanon, NH, US | 4 | 2021 |
| Lebanon, OH, US | 2 | 2021 |
| Belmont, Massachusetts, US | 1 | 2014 |
| Salt Lake City, UT, US | 1 | 2000 |